Doussot Joël, Mathieu Véronique, Colas Cyril, Molinié Roland, Corbin Cyrielle, Montguillon Josiane, Moreno Y Banuls Laeticia, Renouard Sullivan, Lamblin Frédéric, Dupré Patricia, Maunit Benoit, Kiss Robert, Hano Christophe, Lainé Eric
LBLGC, Université d'Orléans, Orléans, France.
Faculté de Pharmacie, Laboratoire de Cancérologie et de Toxicologie Expérimentale, Université Libre de Bruxelles, Brussels, Belgium.
Planta Med. 2017 Apr;83(6):574-581. doi: 10.1055/s-0042-118650. Epub 2016 Oct 24.
Podophyllotoxin, a lignan still extracted from the rhizomes of (Berberidaceae), is the starting molecule for the semisynthesis of widely used anticancer drugs such as etoposide. However, this source is threatened by the over-collection of . Plants belonging to the Linaceae and Cupressaceae families could be attractive alternative sources with species that contain the lignan podophyllotoxin or its precursors and derivatives. Wild flax species, such as , as well as some and species were investigated for their lignan content, and the antiproliferative capacity of their extracts was assayed on four tumor cell lines. Some of the lignans were detected by LC-HRMS for the first time in these extracts.In addition, lignans purified from these plants and compounds semisynthesized from commercially available podophyllotoxin were tested in terms of their antiproliferative activity. The genus was the most promising given its antiproliferative effects, which were also observed with extracts from and species.The antiproliferative effect of the plant extracts studied here appears to correlate well with the contents of the aryltetralin lignan podophyllotoxin and its glycoside as well as with deoxypodophyllotoxin and 6-methoxypodophyllotoxin. The strongest correlation between the lignan content of the extracts and the antiproliferative activity was observed for 6-methoxypodophyllotoxin. Regarding the possibility of producing large renewable amounts of 6-methoxypodophyllotoxin, this molecule could be of interest to produce new anticancer drugs and to bypass the resistance mechanisms against podophyllotoxin-derived drugs.
鬼臼毒素是一种仍从小檗科植物根茎中提取的木脂素,是广泛使用的抗癌药物如依托泊苷半合成的起始分子。然而,这种来源受到该植物过度采集的威胁。亚麻科和柏科植物可能是有吸引力的替代来源,其一些物种含有木脂素鬼臼毒素或其前体及衍生物。对野生亚麻物种,如 ,以及一些 和 物种的木脂素含量进行了研究,并在四种肿瘤细胞系上测定了其提取物的抗增殖能力。在这些提取物中,首次通过液相色谱 - 高分辨质谱检测到了一些木脂素。此外,还测试了从这些植物中纯化的木脂素以及从市售鬼臼毒素半合成的化合物的抗增殖活性。鉴于其抗增殖作用, 属是最有前景的, 属和 属物种的提取物也观察到了这种作用。本文研究的植物提取物的抗增殖作用似乎与芳基四氢萘木脂素鬼臼毒素及其糖苷以及脱氧鬼臼毒素和6 - 甲氧基鬼臼毒素的含量密切相关。提取物中木脂素含量与抗增殖活性之间最强的相关性是6 - 甲氧基鬼臼毒素。关于大量可再生生产6 - 甲氧基鬼臼毒素的可能性,这种分子对于生产新的抗癌药物以及绕过对鬼臼毒素衍生药物的耐药机制可能具有重要意义。